Dr. Roger Sur

And even more fortunately, it didn't translate into clinical trauma. So again, in the RCT and in our use, anecdotally, it really is a safe device, but it just was not adequate enough because we couldn't see. We're using fluoroscopy. Even though it was steerable, we couldn't see it visually.

And even more fortunately, it didn't translate into clinical trauma. So again, in the RCT and in our use, anecdotally, it really is a safe device, but it just was not adequate enough because we couldn't see. We're using fluoroscopy. Even though it was steerable, we couldn't see it visually.

That remains a problem, actually, which is a whole other conversation with machine learning that I would love to talk to you about some of our ideas and some of the things that we're doing. But I think machine learning will solve some of those problems because we have not solved that problem. So you're on to the next set of problems.

That remains a problem, actually, which is a whole other conversation with machine learning that I would love to talk to you about some of our ideas and some of the things that we're doing. But I think machine learning will solve some of those problems because we have not solved that problem. So you're on to the next set of problems.

That remains a problem, actually, which is a whole other conversation with machine learning that I would love to talk to you about some of our ideas and some of the things that we're doing. But I think machine learning will solve some of those problems because we have not solved that problem. So you're on to the next set of problems.

So you're obviously a student enough to realize, even though you're an oncologist, you realize we haven't solved all the problems. There's so many more problems that we have to do, which... Which makes it fun to be in research. So you're right. Size is a problem. Obstruction is a problem. We had to figure that out. We had to make sure it was safe. Above all else, it had to be safe.

So you're obviously a student enough to realize, even though you're an oncologist, you realize we haven't solved all the problems. There's so many more problems that we have to do, which... Which makes it fun to be in research. So you're right. Size is a problem. Obstruction is a problem. We had to figure that out. We had to make sure it was safe. Above all else, it had to be safe.

So you're obviously a student enough to realize, even though you're an oncologist, you realize we haven't solved all the problems. There's so many more problems that we have to do, which... Which makes it fun to be in research. So you're right. Size is a problem. Obstruction is a problem. We had to figure that out. We had to make sure it was safe. Above all else, it had to be safe.

And then we had to overcome the obstacles that would occur like obstruction.

And then we had to overcome the obstacles that would occur like obstruction.

And then we had to overcome the obstacles that would occur like obstruction.

Yeah, with the 1.0, it was like that. With the 2.0 now, we were just literally as you're lasering, you see the fragments just coming across your screen, collecting to your little container attached to the scope. And then when you want to really turn on the suction, it has this spray, a very proprietary spray action that comes out from the scope.

Yeah, with the 1.0, it was like that. With the 2.0 now, we were just literally as you're lasering, you see the fragments just coming across your screen, collecting to your little container attached to the scope. And then when you want to really turn on the suction, it has this spray, a very proprietary spray action that comes out from the scope.

Yeah, with the 1.0, it was like that. With the 2.0 now, we were just literally as you're lasering, you see the fragments just coming across your screen, collecting to your little container attached to the scope. And then when you want to really turn on the suction, it has this spray, a very proprietary spray action that comes out from the scope.

It's different than just irrigation coming out of scope. There's multiple sprays coming off the scope that surround the stone and bring the stone back to the scope. And then it's got a seven French channel that you can evacuate large fragments through the scope.

It's different than just irrigation coming out of scope. There's multiple sprays coming off the scope that surround the stone and bring the stone back to the scope. And then it's got a seven French channel that you can evacuate large fragments through the scope.

It's different than just irrigation coming out of scope. There's multiple sprays coming off the scope that surround the stone and bring the stone back to the scope. And then it's got a seven French channel that you can evacuate large fragments through the scope.

It was initially homegrown. I had to learn the hard way, truthfully. I didn't realize that everything I do in the university is owned by the university. So that initial patent that George and I spent a couple thousand dollars on, that really wasn't very useful. That's a nice write-off for us. The university's like, no, you have to go through us. So we had to go through them.

It was initially homegrown. I had to learn the hard way, truthfully. I didn't realize that everything I do in the university is owned by the university. So that initial patent that George and I spent a couple thousand dollars on, that really wasn't very useful. That's a nice write-off for us. The university's like, no, you have to go through us. So we had to go through them.

It was initially homegrown. I had to learn the hard way, truthfully. I didn't realize that everything I do in the university is owned by the university. So that initial patent that George and I spent a couple thousand dollars on, that really wasn't very useful. That's a nice write-off for us. The university's like, no, you have to go through us. So we had to go through them.